Molecular imaging of plaques in coronary arteries with PET and SPECT

被引:0
|
作者
ZhongHua SUN [1 ]
Hairil Rashmizal [2 ]
Lei XU [3 ]
机构
[1] Discipline of Medical Imaging,Department of Imaging and Applied Physics,Curtin University,Perth,Western Australia ,Australia
[2] Department of Medical Imaging,Faculty of Health Sciences,University Technology MARA(UiTM),Selangor ,Malaysia
[3] Department of Radiology,Beijing Anzhen Hospital,Capital Medical
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Coronary artery disease remains a major cause of mortality.Presence of atherosclerotic plaques in the coronary artery is responsible for lumen stenosis which is often used as an indicator for determining the severity of coronary artery disease.However,the degree of coronary lumen stenosis is not often related to compromising myocardial blood flow,as most of the cardiac events that are caused by atherosclerotic plaques are the result of vulnerable plaques which are prone to rupture.Thus,identification of vulnerable plaques in coronary arteries has become increasingly important to assist identify patients with high cardiovascular risks.Molecular imaging with use of positron emission tomography(PET) and single photon emission computed tomography(SPECT) has fulfilled this goal by providing functional information about plaque activity which enables accurate assessment of plaque stability.This review article provides an overview of diagnostic applications of molecular imaging techniques in the detection of plaques in coronary arteries with PET and SPECT.New radiopharmaceuticals used in the molecular imaging of coronary plaques and diagnostic applications of integrated PET/CT and PET/MR1 in coronary plaques are also discussed.
引用
收藏
页码:259 / 273
页数:15
相关论文
共 50 条
  • [31] Imaging Markers: PET/SPECT
    Remy, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 892 - 892
  • [32] Biomedical imaging: SPECT and PET
    Lecomte, Roger
    NUCLEAR PHYSICS METHODS AND ACCELERATORS IN BIOLOGY AND MEDICINE, 2007, 958 : 115 - 122
  • [33] Molecular imaging using PET and SPECT for identification of breast cancer subtypes
    Liu, Hao
    Chen, Yao
    Wu, Shuang
    Song, Fahuan
    Zhang, Hong
    Tian, Mei
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (11) : 1116 - 1124
  • [34] SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
    Wang, Xiaobo
    Feng, Han
    Zhao, Shichao
    Xu, Junling
    Wu, Xinyu
    Cui, Jing
    Zhang, Ying
    Qin, Yuhua
    Liu, Zhiguo
    Gao, Tang
    Gao, Yongju
    Zeng, Wenbin
    ONCOTARGET, 2017, 8 (12) : 20476 - 20495
  • [35] PET and SPECT imaging in psychiatry
    Malizia, AL
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S359 - S359
  • [36] SPECT and PET Imaging of Meningiomas
    Valotassiou, Varvara
    Leondi, Anastasia
    Angelidis, George
    Psimadas, Dimitrios
    Georgoulias, Panagiotis
    SCIENTIFIC WORLD JOURNAL, 2012,
  • [37] Parametric Imaging With PET and SPECT
    Gallezot, Jean-Dominique
    Lu, Yihuan
    Naganawa, Mika
    Carson, Richard E.
    IEEE TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES, 2020, 4 (01) : 1 - 23
  • [38] MOLECULAR IMAGING WITH SPECT AND PET IN EXPLORATORY INVESTIGATIONAL NEW DRUG STUDIES
    Gomes, C. M. F.
    Abrunhosa, A. J.
    Pauwels, E. K. J.
    DRUGS OF THE FUTURE, 2011, 36 (01) : 69 - 77
  • [39] Molecular imaging of gene expression and protein function in vivo with PET and SPECT
    Sharma, V
    Piwnica-Worms, D
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 16 (04) : 336 - 351
  • [40] Molecular imaging of cancer-evaluating characters of individual cancer by PET/SPECT imaging
    Saga, Tsuneo
    Koizumi, Mitsuru
    Furukawa, Takako
    Yoshikawa, Kyosan
    Fujibayashi, Yasuhisa
    CANCER SCIENCE, 2009, 100 (03) : 375 - 381